A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: dot (14), spot (88), point (473), stop (1000)

InP- VTD PACE (SC) Bortezomib (SC) Cisplatin Cyclophosphamide Dexamethasone Doxorubicin Etoposide Thalidomide

Description
Chemotherapy Protocol MULTIPLE MYELOMA VTD-PACE (SC)-BORTEZOMIB (SC)-CISPLATIN-CYCLOPHOSPHAMIDEDEXAMETHASONE-DOXORUBICIN-ETOPOSIDE-THALIDOMIDE (VTD-
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/InP-VTD-PACE-SC-Bortezomib-SC-Cisplatin-Cyclophosphamide-Dexamethasone-Doxorubicin-Etoposide-Thalidomide.pdf

Dexamethasone(40)-Pomalidomide

Description
Regimen Chemotherapy Protocol Myeloma Dexamethasone (40)-Pomalidomide • Myeloma – Dexamethasone (40)-Pomalidomide Indication • Po
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Dexamethasone-40-Pomalidomide.pdf

Dexamethasone(20)-Pomalidomide

Description
Chemotherapy Protocol Myeloma Dexamethasone (20)-Pomalidomide Regimen • Myeloma – Dexamethasone (20)-Pomalidomide Indication • Po
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Dexamethasone-20-Pomalidomide.pdf

Clarithromycin-Dexamethasone_40_Pomalidomide

Description
Chemotherapy Protocol Myeloma Clarithromycin-Dexamethasone (40)-Pomalidomide Regimen • Myeloma – Clarithromycin-Dexamethasone (40
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Clarithromycin-Dexamethasone-40-Pomalidomide.pdf

Clarithromycin-Dexamethasone_20_Pomalidomide

Description
Chemotherapy Protocol Myeloma Clarithromycin-Dexamethasone (20)-Pomalidomide Regimen • Myeloma – Clarithromycin-Dexamethasone (20
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Clarithromycin-Dexamethasone-20-Pomalidomide.pdf

Dacarbazine Ver 1

Description
Chemotherapy Protocol SKIN CANCER DACARBAZINE Regimen Skin – Dacarbazine Indication Dacarbazine is recommended as a first line option for unresectable
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDacarbazineVer1.pdf

Bevacizumab ver 1

Description
Chemotherapy Protocol CNS CANCER BEVACIZUMAB This protocol may require funding. This is an unlicensed indication for bevacizumab. Regimen CNS-Bevac
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Bevacizumab-ver-1.pdf

Epirubicin (7) Ver1.1

Description
Chemotherapy Protocol BREAST CANCER EPIRUBICIN (7 day) Regimen Breast Cancer – Epirubicin (7 day) Indication Treatment of locally advanced or metast
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastEpirubicin7Ver11.pdf

Epirubicin (21) Ver 1.1

Description
Chemotherapy Protocol BREAST CANCER EPIRUBICIN (21 day) Regimen Breast Cancer – Epirubicin (21 day) Indication Treatment of locally advanced or meta
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastEpirubicin21Ver11.pdf

Doxorubicin (21) Ver1.1

Description
Chemotherapy Protocol BREAST CANCER DOXORUBICIN (21 day) Regimen Breast Cancer – Doxorubicin (21 day) Indication Treatment of locally advanced or me
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastDoxorubicin21Ver11.pdf
111 to 120 of 680
Previous … 10 11 12 13 14 … Next